Dr. Clay Siegall currently serves in three positions in Seattle Genetics a company he co-founded, he is the CEO, the Chairman as well as the president. He did not just get to this positions he had interest in the field, he attained a B.S degree in Zoology from Maryland University and went ahead to get a P.H.D in Genetics this is after achieving his doctorate from the University of Washington. Further, he has experience in the medical fields as he has worked for nearly a decade for two medical research centers. Also, he serves as a board member to several private biotechnology companies such as Alder Biopharmaceuticals, Ultragenyx Pharmaceuticals, and Mirna Therapeutics.
On Dec 7, 2016 Smartmoney posted an article about Dr. Clay and Seattle Genetics looking at the company net worth and the company contribution to the cancer world. According to the article, Clay is a man to be celebrated for contributing to cancer research intensively currently holding 15 patents and has 70 publications on cancer research. Further, according to the article, DR.Clay does hold a prestigious position in the greatest Cancer Research & Development Centers that is Seattle Genetics. The company is into biotechnology but specializes in commercialization and development of antibody based therapy. The company has included a very beneficial drug, an antibody in their therapy that conjugates and directly injects cancer cells with killing agents. The company is not only succeeding in cancer treatment but it is contributing to the economy, and as of 2016, the company estimated net worth was $ 4.7 Billion. The company is indeed ready for commercialization.